Sunesis Pharmaceuticals (SNSS) Tops Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts SNSS Hot Sheet
Price: $5.32 --0%
Financial Fact:
Loss from operations: -9.99M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Loss from operations: -9.99M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q1 EPS of ($0.13), $0.03 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $854 thousand versus the consensus estimate of $980 thousand.
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Corporación América Airports S.A. (CAAP) Misses Q2 EPS by 18c
- Sypris Solutions (SYPR) Reports Q2 Loss of $0.14
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
